Ferrochelatase
- PMID: 10582332
- DOI: 10.1016/s1357-2725(99)00066-7
Ferrochelatase
Abstract
Ferrochelatase, the terminal enzyme of the heme biosynthetic pathway, catalyzes the insertion of ferrous iron into protoporphyrin IX. It is encoded by a single gene, and mutations in the human gene are associated with the inherited disorder, erythropoietic protoporphyria. With the development of heterologous overexpression systems and the ready availability of recombinant ferrochelatase, new structural elements have been identified and new aspects of the ferrochelatase-catalyzed reaction mechanism have been unraveled. Namely, a [2Fe-2S] cluster is a prosthetic group in mammalian ferrochelatase, a conserved and essential histidine residue appears to be involved in the binding of the metal substrate and a conserved glutamate residue has been proposed to have a catalytic role. The three-dimensional structure for Bacillus subtilis ferrochelatase, the only known 'water-soluble' ferrochelatase, revealed that the protein contains two similar domains, each of which has a four-stranded beta-sheet flanked by alpha-helices; the active site was modeled to be in a cleft defined by the two domains. The definition of the structure and catalytic mechanism of ferrochelatase should help in the interpretation of the impact caused by erythropoietic porphyria mutations.
Similar articles
-
Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis.Structure. 1997 Nov 15;5(11):1501-10. doi: 10.1016/s0969-2126(97)00299-2. Structure. 1997. PMID: 9384565
-
The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.J Bioenerg Biomembr. 1995 Apr;27(2):231-8. doi: 10.1007/BF02110038. J Bioenerg Biomembr. 1995. PMID: 7592570 Review.
-
Ferrochelatase at the millennium: structures, mechanisms and [2Fe-2S] clusters.Cell Mol Life Sci. 2000 Dec;57(13-14):1909-26. doi: 10.1007/pl00000672. Cell Mol Life Sci. 2000. PMID: 11215517 Free PMC article. Review.
-
Erythropoietic protoporphyria: four novel frameshift mutations in the ferrochelatase gene.J Invest Dermatol. 1997 Nov;109(5):688-91. doi: 10.1111/1523-1747.ep12338217. J Invest Dermatol. 1997. PMID: 9347801
-
Examination of ferrochelatase mutations that cause erythropoietic protoporphyria.Blood. 1998 May 15;91(10):3980-5. Blood. 1998. PMID: 9573038
Cited by
-
Interactions of apomyoglobin with membranes: mechanisms and effects on heme uptake.Protein Sci. 2007 Mar;16(3):391-400. doi: 10.1110/ps.062531207. Epub 2007 Jan 22. Protein Sci. 2007. PMID: 17242377 Free PMC article.
-
Evaluating the Role of the Steroid and Xenobiotic Receptor (SXR/PXR) in PCB-153 Metabolism and Protection against Associated Adverse Effects during Perinatal and Chronic Exposure in Mice.Environ Health Perspect. 2020 Apr;128(4):47011. doi: 10.1289/EHP6262. Epub 2020 Apr 30. Environ Health Perspect. 2020. PMID: 32352317 Free PMC article.
-
CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening.Int J Mol Sci. 2024 Oct 8;25(19):10819. doi: 10.3390/ijms251910819. Int J Mol Sci. 2024. PMID: 39409147 Free PMC article.
-
Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.Biochemistry. 2011 Mar 8;50(9):1535-44. doi: 10.1021/bi101170p. Epub 2011 Feb 10. Biochemistry. 2011. PMID: 21222436 Free PMC article.
-
Iron Homeostasis in Azotobacter vinelandii.Biology (Basel). 2023 Nov 12;12(11):1423. doi: 10.3390/biology12111423. Biology (Basel). 2023. PMID: 37998022 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
